Renal Research Institute
New York, 10128, United States
NCT Number: NCT01825590
A difference between dialysate and serum sodium concentration leads to diffusive sodium transfer across the dialyzer membrane. The consequences of diffusive sodium flux into the patient can be chronic sodium overload leading to overhydration, hypertension, cardiovascular disease, and other problems. Diffusive sodium flux out of the patient can lead to intradialytic blood pressure instability. A simple strategy for alignment of dialysate and serum sodium concentrations was implemented starting in April/May 2010 in order to minimize the problems particularly associated with chronic sodium overload.
Looking for future studies?
Notify Me18 year–88 year
All sexes
Observational
New York, 10128, United States
The purpose of this database analysis is to assess the impact that this operational change has had in the short, medium and long term on key clinical and laboratory parameters in the patients, including blood pressure, body weight, interdialytic weight gain, serum electrolytes, intradialytic saline administration, missed treatments, hospitalizations, medication, inflammatory markers, etc. All subjects included in the final dataset will be matched with dialysis patients receiving treatment in other dialysis clinics of the Renal Research Institute who were not subject to the operational change. This will lead to the development of a matched cohort of equal size unexposed to dialysate to serum sodium alignment.
The analysis is planned to investigate treatment effects, and test the effects of dialysate to serum sodium alignment for interactions and associations between those laboratory and clinical parameters. The extent and magnitude of sodium alignment (the operational change) will also be assessed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Each dialysis treatment (3x per week) - 2 years of treatment data
Time frame: Each dialysis treatment (3x per week)- 2 years of treatment data
Time frame: Per occurence during the entire follow-up period of 2 years
Time frame: Each treatment (3x per week)- 2 years of treatment data
Time frame: Each treatment (3x per week)- 2 years of treatment data
Time frame: Per occurance
Time frame: Each treatment (3x per week)- 2 years of treatment data
Time frame: Per occurance
Time frame: Per occurance
Renal Research Institute
Other
Effects of Simple Sodium Alignment on Short-, Medium- and Long-term Clinical and Laboratory Outcome Measures
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02513303
Arteriovenous Fistula, Arteriovenous Malformations
Huntsville, Alabama, United States
View Trial DetailsNCT05425056
Arteriovenous Fistula, Arteriovenous Malformations
San Diego, California, United States
View Trial DetailsNCT02870829
Calcinosis, Calcium Metabolism Disorders
Singapore
View Trial DetailsNCT02950389
Complication of Hemodialysis
Bologna, Italy
View Trial Details